Page 7 - Upper Limb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Neurotoxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and...

Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in...

Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in ambulatory patients with DMD expected 3Q 2023 ... | June 7, 2023

1. Patients with chronic upper limb spasticity post-stroke randomized to radial extracorporeal shock wave therapy (rESWT) had greater symptomatic and functional improvement than patients randomized to transcutaneous electrical nerve stimulation (TENS). Evidence Rating Level: 1 (Excellent) It is estimated that 43% of patients who survive a stroke experience upper limb spasticity, which can be functionally

Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial 1. Rivaroxaban is safe and effective for venous thromboembolism (VTE) prophylaxis post-bariatric surgery. 2. Similar efficacy and safety profiles were observed with 10 mg rivaroxaban daily for either 7 or 28 days. Evidence Rating Level: 1 (Excellent) Individuals